Jaguar Animal Health (1JA2) AI Stock Analysis

0 Followers

Jaguar Animal Health

(Frankfurt:1JA2)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Specialized Animal-Health PortfolioA commercial portfolio addressing gastrointestinal conditions across companion animals and livestock gives Jaguar an established operating base and a focused therapeutic identity. Plant-derived formulations and specialized veterinary applications may support differentiated positioning as the company expands adoption.

Negative Factors

Persistent Operating LossesDeep operating and net losses show that the current cost structure is not yet aligned with the company’s revenue base. Continued cash consumption could require additional financing, limiting strategic flexibility and delaying the point at which strong gross margins translate into sustainable earnings.

Jaguar Animal Health (1JA2) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 1.12M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): 0.0
Beta (1Y): -0.07
Revenue Growth: 119.33%
EPS Growth: 86.53%
Country: Germany
Employees: 47
Sector: Healthcare
Sector Strength: 51
Industry: Biotechnology

Jaguar Animal Health Business Overview & Revenue Model

Company Description

Jaguar Health, Inc., a commercial-stage pharmaceutical firm, specializes in developing prescription therapies for both human and animal patients afflicted by gastrointestinal ailments, particularly chronic and severe diarrhea. Its operations are stru...

Jaguar Animal Health Risk Analysis

Jaguar Animal Health disclosed 70 risk factors in its most recent earnings report. Jaguar Animal Health reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Jaguar Animal Health Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:1JA2 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
EVGN	40Underperform	$6.72M	-0.37	761.97%	―	-80.59%	59.44%
CODX	39Underperform	$2.74M	-0.01	-322.92%	―	28.89%	34.53%
GOVX	39Underperform	$32.67M	-0.01	-743.66%	―	-100.00%	77.63%

* Healthcare Sector Average

Performance Comparison

DE:1JA2 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:1JA2	Jaguar Animal Health Inc.	99225.00	0.00	0.00%
EVGN	Evogene Ltd.	0.40	-0.79	-66.81%
GOVX	Geovax Labs, Inc.	2.16	-279.24	-99.23%
CODX	Co-Diagnostics	0.28	-10.88	-97.52%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Jaguar Animal Health AI Stock Analysis